ArticleBMC urology2017

A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer.

Hae Su Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.